ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 957,57
0,54%
Dow Jones
38 675,68
1,18%
DAX
18 001,60
0,54%
Brent Oil
82,765
0,00%
Bitcoin
63 582,50
1,10%
Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. PaxMedica Inc (PXMD)

  7. PaxMedica Inc (PXMD) Actualités

PXMD PaxMedica Inc

0,6883
0,00 (0,00%)
03 Mai 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
PaxMedica Inc PXMD NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
0,00 0,00% 0,6883 02:00:00
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
0,6883 0,6883
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
26/4/202414:30GLOBEPaxMedica's CEO and Malawi Health Official Discuss Urgent..
23/4/202414:30GLOBEPaxMedica Responds to Emergency Request for IV Suramin and..
16/4/202422:30GLOBEPaxMedica Receives Emergency Request for IV Suramin from..
11/4/202422:30GLOBEPaxMedica Achieves Key Milestone in the Development of..
13/3/202413:20GLOBEPaxMedica Updated Company Presentation Highlighting..
11/3/202421:45EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
23/2/202423:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/2/202402:11EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
31/1/202423:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/1/202423:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/1/202423:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/1/202423:20EDGAR2Form 8-K - Current report
12/1/202423:27EDGAR2Form 8-K - Current report
21/12/202314:00EDGAR2Form 8-K - Current report
30/11/202322:07EDGAR2Form 8-K - Current report
29/11/202322:33EDGAR2Form SC 13G - Statement of acquisition of beneficial..
29/11/202322:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/11/202322:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/11/202322:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/11/202322:05EDGAR2Form 8-K - Current report
22/11/202322:24EDGAR2Form 8-K - Current report
22/11/202322:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/11/202314:51EDGAR2Form 424B4 - Prospectus [Rule 424(b)(4)]
21/11/202306:15EDGAR2Form EFFECT - Notice of Effectiveness
17/11/202314:00GLOBEPaxMedica Inc. Featured in Syndicated Broadcast Highlighting..
16/11/202322:27EDGAR2Form S-1/A - General form for registration of securities..
09/11/202314:00GLOBEPaxMedica's Chief Medical Officer Discusses FDA Meeting..
09/11/202313:18EDGAR2Form 8-K - Current report
09/11/202312:02EDGAR2Form S-1 - General form for registration of securities under..
02/11/202313:30GLOBEPaxMedica Engages Bourne Partners to Explore Future..
31/10/202313:00GLOBEPaxMedica Acquires Suramin Research Assets from Rediscovery..
30/10/202321:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/10/202321:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/10/202321:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/10/202321:05EDGAR2Form 8-K - Current report
30/10/202316:30GLOBEPaxMedica Announces 1-for-17 Reverse Stock Split
26/10/202319:51GLOBEPaxMedica's Research on Low Dose Suramin for Autism Spectrum..
18/10/202316:10GLOBEThe Bell2Bell Podcast featuring Howard Weisman, CEO and Buzz..
27/9/202322:05EDGAR2Form 8-K - Current report
11/9/202322:05EDGAR2Form DEF 14A - Other definitive proxy statements
06/9/202322:25EDGAR2Form 8-K - Current report
01/9/202322:33EDGAR2Form PRE 14A - Other preliminary proxy statements
30/8/202322:26EDGAR2Form 144 - Report of proposed sale of securities
30/8/202322:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/8/202322:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/8/202322:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/8/202314:00GLOBEPaxMedica to Present at the H.C. Wainwright 25th Annual..
17/8/202322:05EDGAR2Form 8-K - Current report
16/8/202315:00EDGAR2Form 8-K - Current report
16/8/202314:30GLOBEPaxMedica Appoints David Hough M.D. as Chief Medical Officer

Dernières Valeurs Consultées

NASDAQ
PXMD
PaxMedica
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés